↓ Skip to main content

Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells

Overview of attention for article published in Molecular Cancer Therapeutics, November 2007
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#5 of 3,686)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Citations

dimensions_citation
174 Dimensions

Readers on

mendeley
268 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells
Published in
Molecular Cancer Therapeutics, November 2007
DOI 10.1158/1535-7163.mct-07-0371
Pubmed ID
Authors

Sean D. McAllister, Rigel T. Christian, Maxx P. Horowitz, Amaia Garcia, Pierre-Yves Desprez

Twitter Demographics

The data shown below were collected from the profiles of 186 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 268 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 4 1%
United Kingdom 3 1%
Netherlands 1 <1%
Italy 1 <1%
Japan 1 <1%
Spain 1 <1%
Unknown 257 96%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 50 19%
Student > Master 48 18%
Student > Ph. D. Student 43 16%
Researcher 40 15%
Other 17 6%
Other 28 10%
Unknown 42 16%
Readers by discipline Count As %
Agricultural and Biological Sciences 53 20%
Biochemistry, Genetics and Molecular Biology 43 16%
Medicine and Dentistry 39 15%
Pharmacology, Toxicology and Pharmaceutical Science 15 6%
Chemistry 13 5%
Other 53 20%
Unknown 52 19%

Attention Score in Context

This research output has an Altmetric Attention Score of 565. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 May 2022.
All research outputs
#29,958
of 21,380,143 outputs
Outputs from Molecular Cancer Therapeutics
#5
of 3,686 outputs
Outputs of similar age
#1,220
of 327,632 outputs
Outputs of similar age from Molecular Cancer Therapeutics
#1
of 32 outputs
Altmetric has tracked 21,380,143 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,686 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.9. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 327,632 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 32 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.